Tag: biosimilar vs generic

Insulin Biosimilars: What You Need to Know About Cost, Safety, and Market Options

Jan, 17 2026| 1 Comments

Insulin biosimilars offer safe, affordable alternatives to branded insulins, with proven effectiveness and cost savings of 15-30%. Learn which ones are available, why adoption is slow, and how patients and providers can make the switch.

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Dec, 26 2025| 14 Comments

The FDA doesn't rate biosimilars like generics-they undergo a rigorous, science-based approval process to prove they're highly similar to reference biologics with no clinically meaningful differences in safety or effectiveness.